Modelling hepatitis C virus infection and the development of hepatocellular carcinoma

Journal of Theoretical Biology

Volumn 305, Issue , 2012, Pages 24-29

  Chakrabarty, Siddhartha P ^a   Murray, John M ^b,c  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hepatitis C; Hepatocellular carcinoma; Latin hypercube sampling; Ordinary differential equation; Stochastic model

Indexed keywords

CANCER; COMPUTER SIMULATION; HEALTH RISK; HEPATITIS; IMMUNE RESPONSE; INFECTIVITY; MUTATION; NUMERICAL MODEL; VIRUS;

ANTIVIRAL THERAPY; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER RISK; CELL PROLIFERATION; CELLULAR IMMUNITY; DISEASE COURSE; DISEASE DURATION; DISEASE MODEL; DISEASE SIMULATION; HEPATITIS C; HEPATITIS C VIRUS; INCIDENCE; LIVER CELL; LIVER CELL CARCINOMA; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; STOCHASTIC MODEL; VIRUS INFECTIVITY; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE PROGRESSION; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; STOCHASTIC PROCESSES; TIME FACTORS;

HEPATITIS C VIRUS;

EID: 84860113497     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.03.030     Document Type: Article

References (28)

1. Beld M., Penning M., McMorrow M., Gorgels J., Hoek A.V.D., Goudsmit J. Different Hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J. Clin. Microbiol. 1998, 36(4):872-877.
2. Castello G., Scala S., Palmieri G., Curley S.A., Izzo F. HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin. Immunol. 2010, 134:237-250.
3. Ciupe S.M., Ribeiro R.M., Nelson P.W., Dusheiko G., Perelson A.S. The role of cells refractory to productive infection in acute hepatitis B viral dynamics. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(12):5050-5055.
4. Cox A.L., Mosbruger T., Lauer G.M., Pardoll D., Thomas D.L., Ray S.C. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 2005, 42(1):104-112.
5. Dahari H., Major M., Zhang X., Mihalik K., Rice C.M., et al. Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology 2005, 128:1056-1066.
6. Dahari H., Feliu A., Garcia-Retortillo M., Forns X., Neumann A.U. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J. Hepatol. 2005, 42:491-498.
7. Dahari H., Lo A., Ribeiro R.M., Perelson A.S. Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy. J. Theor. Biol. 2007, 247:371-381.
8. Dixit N.M., Layden-Almer J.E., Layden T.J., Perelson A.S. Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 2004, 432:922-924.
9. Farci P., Shimoda A., Coiana A., Diaz G., Reddis G., et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000, 288:339-344.
10. Glasserman P. Monte Carlo Methods in Financial Engineering 2004, Springer, NY, USA.
11. Ikeda K., Arase Y., Saitoh S., Kobayashi M., Someya T., et al. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts. J. Hepatol. 2006, 44:1089-1097.
12. Khan M.H., Farrell G.C., Byth K., Weltman M., George J., Samarasinghe D., Kench J., Kaba S., Crewe E., Liddle C. Which patients with hepatitis C develop liver complications. Hepatology 2000, 31:513-520.
13. Mackay I.R. Hepatoimmunology: a perspective. Immunol. Cell Biol. 2002, 80(1):36-44.
14. Mason W.S., Litwin S., Xu C., Jilbert A.R. Hepatocyte turnover in transient and chronic hepadnavirus infections. J. Viral Hepatol. 2007, 14(Suppl. 1):22-28.
15. Mukhopadhya A. Hepatitis C in India. J. Biosci. 2008, 33(4):465-473.
16. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., Perelson A.S. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998, 282:103-107.
17. Nowak M.A., Bangham C.R. Population dynamics of immune responses to persistent viruses. Science 1996, 272(5258):74-79.
18. Nowak M.A., Anderson R.M., McLean A.R., Wolfs T.F., Goudsmit J., et al. Antigenic diversity thresholds and the development of AIDS. Science 1991, 254:963-969.
19. Nunez M., Soriano V. New hopes for HIV and HCV coinfection in 2004. HIV Clin. Trials 2004, 5:232-251.
20. Pal S.K., Chalamalasetty B.S., Choudhuri G. Hepatitis C: a major health problem of India. Curr. Sci. 2002, 83(9):1058-1059.
21. Powers K.A., Ribeiro R.M., Patel K., Pianko S., Nyberg L., et al. Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transplant. 2006, 12:207-216.
22. Razali K., et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend. 2007, 91:228-235.
23. Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005, 5:215-229.
24. Roe B., Hall W.W. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Expert Rev. Mol. Med. 2008, 10:1-18.
25. Thimme R., Oldach D., Chang K.-M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute Hepatitis C virus infection. J. Exp. Med. 2001, 194(10):1395-1406.
26. Tsai W.-L., Chung R.T. Viral hepatocarcinogenesis. Oncogene 2010, 29:2309-2324.
27. Wodarz D. Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. J. Gen. Virol. 2003, 84:1743-1750.
28. Zhong J., Gastaminza P., Ching J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., Chisari F.V. Persistent hepatitis C virus infection in vitro: co-evolution of virus and host. J. Virol. 2006, 80(22):11082-11093.